Physician profile
Emily E Murphy
NPI 1467681684
$11,075.73
in general payments reported to CMS, 2019-2025
25 companies · $231 in 2025
The $231 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,642 · 2020: $63.94 · 2021: $44.70 · 2022: $5,721 · 2023: $266 · 2024: $106 · 2025: $231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $603.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $603.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,036.26 | 2019-2022 | |
| Hologic Sales and Service, LLC | $211.78 | 2023-2025 | Coolseal Generator |
| Z-Medica, LLC | $115.27 | 2019-2020 | |
| Integra Lifesciences Corporation | $88.54 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Medtronic, INC. | $80.35 | 2022-2025 | Signia, Sonicision, Ligasure |
| Acell, INC. | $58.60 | 2019-2020 | |
| Kci USA, INC. | $55.30 | 2020-2023 | Prevena, V.A.C. Dermatac, V.A.C. Veraflo |
| Enterra Medical, INC. | $46.42 | 2022 | |
| Zimmer Biomet Holdings, INC. | $39.66 | 2023 | Advantagerib |
| Mallinckrodt Enterprises LLC | $35.67 | 2019 | |
| Janssen Pharmaceuticals, INC | $32.95 | 2023 | Xarelto |
| Solventum Corporation | $32.66 | 2025 | V.A.C.Ulta, 3m Cavilon, Prevena |
| Davol INC. | $27.92 | 2019-2023 | Phasix Mesh |
| Microline Surgical INC | $24.70 | 2021 | |
| Organogenesis INC. | $23.99 | 2023 | Puraply |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $22.38 | 2022 | |
| Allergan, INC. | $22.19 | 2019 | |
| Innocoll Pharmaceuticals Limited | $20.00 | 2021 | |
| Eagle Pharmaceuticals, INC. | $19.39 | 2023 | |
| Mimedx Group, INC. | $17.98 | 2025 | |
| Boston Scientific Corporation | $15.92 | 2024 | Spyglass Discover |
| Ethicon US, LLC | $15.50 | 2023 | Ethicon, Vistaseal |
| Medtronic USA, INC. | $12.16 | 2019 | |
| Kerecis Limited | $11.79 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Thd America, INC. | $8.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.